Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-26 4:31 pm Sale | 2024-12-20 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 7,404,869 12.000% | -629,131 (-7.83%) | Filing History |
| 2024-11-14 5:21 pm Sale | 2024-03-31 | 13G | Passage Bio, Inc. PASG | Erste Asset Management GmbH | 2,455,800 4.420% | -505,000 (-17.06%) | Filing History |
| 2024-11-14 5:01 pm Purchase | 2023-12-31 | 13G | Passage Bio, Inc. PASG | Erste Asset Management GmbH | 2,960,800 5.400% | 2,960,800 (New Position) | Filing History |
| 2024-11-14 12:03 pm Purchase | 2024-09-30 | 13G | Passage Bio, Inc. PASG | Vestal Point Capital LP | 6,100,000 9.900% | 6,100,000 (New Position) | Filing History |
| 2024-08-09 7:06 pm Sale | 2024-08-07 | 13D | Passage Bio, Inc. PASG | Versant Venture Capital VI L.P. | 0 0.000% | -4,026,417 (Position Closed) | Filing History |
| 2024-08-09 5:15 pm Purchase | 2024-08-07 | 13G | Passage Bio, Inc. PASG | Lynx1 Capital Management LP | 8,426,955 13.600% | 3,581,084 (+73.90%) | Filing History |
| 2024-05-29 4:35 pm Unchanged | 2024-05-24 | 13D | Passage Bio, Inc. PASG | Versant Venture Capital VI L.P. | 4,026,417 6.500% | 0 (Unchanged) | Filing History |
| 2024-04-12 5:35 pm Unchanged | 2024-04-09 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 8,034,000 13.000% | 0 (Unchanged) | Filing History |
| 2024-03-29 4:15 pm Purchase | 2024-03-19 | 13G | Passage Bio, Inc. PASG | Lynx1 Capital Management LP | 4,845,871 8.700% | 4,466,712 (+1178.06%) | Filing History |
| 2024-02-14 09:21 am Sale | 2023-12-31 | 13G | Passage Bio, Inc. PASG | Lynx1 Capital Management LP | 379,159 0.700% | -2,976,758 (-88.70%) | Filing History |
| 2023-11-09 5:27 pm Unchanged | 2023-08-07 | 13D | Passage Bio, Inc. PASG | Versant Venture Capital VI L.P. | 4,026,417 7.300% | 0 (Unchanged) | Filing History |
| 2023-06-29 4:36 pm Purchase | 2023-06-27 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 8,034,000 14.700% | 1,192,577 (+17.43%) | Filing History |
| 2023-06-15 10:25 am Sale | 2023-06-13 | 13D | Passage Bio, Inc. PASG | Frazier Life Sciences IX L.P. | 2,543,698 4.700% | -1,213,217 (-32.29%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Passage Bio, Inc. PASG | Lynx1 Capital Management LP | 3,355,917 6.200% | 603,495 (+21.93%) | Filing History |
| 2023-02-14 08:53 am Sale | 2022-12-31 | 13G | Passage Bio, Inc. PASG | Deep Track Capital, LP | 0 0.000% | -3,216,997 (Position Closed) | Filing History |
| 2022-09-29 4:30 pm Purchase | 2022-09-19 | 13G | Passage Bio, Inc. PASG | Lynx1 Capital Management LP | 2,752,422 5.100% | 2,752,422 (New Position) | Filing History |
| 2022-08-15 11:29 am Sale | 2022-08-11 | 13D | Passage Bio, Inc. PASG | Frazier Life Sciences IX L.P. | 3,756,915 6.900% | -1,264,523 (-25.18%) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Passage Bio, Inc. PASG | BlackRock Inc. BLK | 1,368,347 2.500% | -2,123,208 (-60.81%) | Filing History |
| 2022-05-05 4:56 pm Purchase | 2022-05-03 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 6,841,423 12.600% | 894,100 (+15.03%) | Filing History |
| 2022-02-14 08:59 am Purchase | 2021-12-31 | 13G | Passage Bio, Inc. PASG | Deep Track Capital, LP | 3,216,997 5.950% | 364,057 (+12.76%) | Filing History |